DK172411B1 - 7-Oxabicycloheptyl-substituerede heterocycliske amid-prostaglandin-analoge samt præparat til inhibering af blodpladeaggregering og bronchokonstriktion - Google Patents

7-Oxabicycloheptyl-substituerede heterocycliske amid-prostaglandin-analoge samt præparat til inhibering af blodpladeaggregering og bronchokonstriktion Download PDF

Info

Publication number
DK172411B1
DK172411B1 DK663189A DK663189A DK172411B1 DK 172411 B1 DK172411 B1 DK 172411B1 DK 663189 A DK663189 A DK 663189A DK 663189 A DK663189 A DK 663189A DK 172411 B1 DK172411 B1 DK 172411B1
Authority
DK
Denmark
Prior art keywords
mmol
mixture
solution
added
stirred
Prior art date
Application number
DK663189A
Other languages
Danish (da)
English (en)
Other versions
DK663189A (da
DK663189D0 (da
Inventor
Philip M Sher
Philip D Stein
David Floyd
Steven E Hall
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of DK663189D0 publication Critical patent/DK663189D0/da
Publication of DK663189A publication Critical patent/DK663189A/da
Application granted granted Critical
Publication of DK172411B1 publication Critical patent/DK172411B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK663189A 1988-12-23 1989-12-22 7-Oxabicycloheptyl-substituerede heterocycliske amid-prostaglandin-analoge samt præparat til inhibering af blodpladeaggregering og bronchokonstriktion DK172411B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28882688A 1988-12-23 1988-12-23
US28882688 1988-12-23

Publications (3)

Publication Number Publication Date
DK663189D0 DK663189D0 (da) 1989-12-22
DK663189A DK663189A (da) 1990-06-24
DK172411B1 true DK172411B1 (da) 1998-05-25

Family

ID=23108806

Family Applications (1)

Application Number Title Priority Date Filing Date
DK663189A DK172411B1 (da) 1988-12-23 1989-12-22 7-Oxabicycloheptyl-substituerede heterocycliske amid-prostaglandin-analoge samt præparat til inhibering af blodpladeaggregering og bronchokonstriktion

Country Status (18)

Country Link
EP (1) EP0374952A3 (zh)
JP (1) JPH02221278A (zh)
KR (1) KR900009639A (zh)
CN (1) CN1031059C (zh)
AU (1) AU617569B2 (zh)
CA (1) CA2006355A1 (zh)
DD (1) DD286359A5 (zh)
DK (1) DK172411B1 (zh)
FI (1) FI97230C (zh)
HU (1) HUT54161A (zh)
IL (1) IL92837A (zh)
MX (1) MX18879A (zh)
NO (1) NO175258C (zh)
NZ (1) NZ231962A (zh)
PH (1) PH27413A (zh)
PL (2) PL165147B1 (zh)
PT (1) PT92768B (zh)
ZA (1) ZA899868B (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ232897A (en) * 1989-04-03 1992-12-23 Squibb & Sons Inc Interphenylene 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogues, preparation and pharmaceutical compositions thereof
DE4035851A1 (de) * 1990-11-10 1992-05-14 Bayer Ag Substituierte aminosaeureamid-derivate deren herstellung und verwendung
NZ233600A (en) * 1989-06-12 1992-10-28 Squibb & Sons Inc 7-oxabicyclo(2.2.1)heptane imidazole prostaglandin analogs and pharmaceutical compositions
US4977174A (en) * 1989-06-12 1990-12-11 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane imidazole prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
US5290799A (en) * 1990-09-19 1994-03-01 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic thioamide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
US5550248A (en) * 1990-11-29 1996-08-27 E.R. Squibb & Sons, Inc. Substituted stryl heterocyclic amido prostaglandin analogs
DE4102042A1 (de) * 1991-01-24 1992-07-30 Bayer Ag Substituierte aminosaeureamid-derivate deren herstellung und verwendung als fungizide
US5135939A (en) * 1991-01-28 1992-08-04 E. R. Squibb & Sons, Inc. Heterocyclic ketone prostaglandin analogs
US5238951A (en) * 1991-02-01 1993-08-24 E. R. Squibb & Sons, Inc. Heterocyclic amido prostaglandin analogs
IE920039A1 (en) * 1991-02-01 1992-08-12 Squibb & Sons Inc Heterocyclic amido prostaglandin analogs
US5158967A (en) * 1991-06-12 1992-10-27 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
US5162352A (en) * 1991-08-22 1992-11-10 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs
US5280034A (en) * 1991-08-23 1994-01-18 E. R. Squibb & Sons, Inc. Bis-heterocyclic prostaglandin analogs
CA2081679A1 (en) * 1991-11-27 1993-05-28 Raj N. Misra Gem-dialkyl-7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
US5399725A (en) * 1993-05-27 1995-03-21 Bristol-Myers Squibb Co. 7-oxabicycloheptane carboxylic acid prostaglandin analog intermediates useful in the preparation of anti-thrombotic and anti-vasospastic compounds and method for preparing same
US5849766A (en) * 1996-05-31 1998-12-15 Eli Lilly And Company Carbamoyl substituted heterocycles
US5849922A (en) * 1996-05-31 1998-12-15 Eli Lilly And Company Preparation of substituted alkenoic acids
US5856584A (en) * 1997-08-06 1999-01-05 The Nutrasweet Company Preparation of 3,3-dimethylbutyraldehyde by oxidation of 3, 3-dimethylbutanol
US5905175A (en) * 1998-05-20 1999-05-18 The Nutrasweet Company Synthesis and purification of 3,3-dimethylbutyraldehyde via oxidation of 1-chloro-3,3-dimethylbutane with dimethyl sulfoxide
CN113912619B (zh) * 2021-11-26 2022-12-06 沈阳药科大学 五味子中提取分离的倍半萜化合物及其方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4456617A (en) * 1983-01-12 1984-06-26 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted amino prostaglandin analogs and their use in inhibiting platelet aggregation and bronchoconstriction
US4663337A (en) * 1986-04-18 1987-05-05 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted amides useful in the treatment of thrombotic disease

Also Published As

Publication number Publication date
FI97230B (fi) 1996-07-31
DK663189A (da) 1990-06-24
PL165147B1 (pl) 1994-11-30
PT92768B (pt) 1995-12-29
CN1043716A (zh) 1990-07-11
FI97230C (fi) 1996-11-11
JPH02221278A (ja) 1990-09-04
IL92837A (en) 1994-06-24
HU8906777D0 (zh) 1990-03-28
HUT54161A (en) 1991-01-28
PL164552B1 (pl) 1994-08-31
ZA899868B (en) 1990-09-26
NO175258B (no) 1994-06-13
NO895170L (no) 1990-06-25
MX18879A (es) 1994-01-31
CA2006355A1 (en) 1990-06-23
IL92837A0 (en) 1990-09-17
FI896249A0 (fi) 1989-12-22
NZ231962A (en) 1992-10-28
DK663189D0 (da) 1989-12-22
AU4729089A (en) 1990-06-28
DD286359A5 (de) 1991-01-24
AU617569B2 (en) 1991-11-28
CN1031059C (zh) 1996-02-21
KR900009639A (ko) 1990-07-05
EP0374952A3 (en) 1991-03-27
EP0374952A2 (en) 1990-06-27
NO895170D0 (no) 1989-12-21
PT92768A (pt) 1990-06-29
PH27413A (en) 1993-06-21
NO175258C (no) 1994-09-21

Similar Documents

Publication Publication Date Title
DK172411B1 (da) 7-Oxabicycloheptyl-substituerede heterocycliske amid-prostaglandin-analoge samt præparat til inhibering af blodpladeaggregering og bronchokonstriktion
EP0391652B1 (en) Interphenylène 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasopastic disease
KR0138498B1 (ko) 신규 이속사졸 유도체 및 그의 염
GB2184118A (en) Bicyclic sulfonamide derivatives
US5587505A (en) Triterpene derivatives and endothelin-receptor antagonists containing the same
JPS5931510B2 (ja) 5,6,7−トリノル−4,8−インタ−m−フエニレンPGI↓2誘導体
GB2359810A (en) Derivatives of isosorbid mononitrate, utilization as vasodilator agents with reduced tolerance
CZ2000804A3 (cs) Způsob výroby proteázového inhibitoru
JPS6233182A (ja) 7−オキサビシクロヘプタン置換ジ酸ジアミドプロスタグランジン類縁体
JPH04247086A (ja) 7−オキサビシクロヘプチル置換複素環式チオアミドプロスタグランジン類縁体
JPS61263980A (ja) 7−オキサビシクロヘプタン置換アリ−ルアミノプロスタグランジン類縁体並びにその血小板凝集および気管支収縮の抑制用途
RU2015980C1 (ru) 7-оксабициклогептилзамещенные гетероциклические амиды или их стереоизомеры в качестве антагонистов рецепторов тромбоксана
EP0718307A2 (fr) Dérivés de 1-oxo-2-(phénylsulfonyl-amino)pentylpipéridine, leur préparation et leur application en thérapeutique
US5281716A (en) Method for preparing 7-oxabicycloheptyl substituted oxazole amide prostaglandin analog intermediates useful in the preparation of anti-thrombotic and anti-vasospastic compounds
US5238951A (en) Heterocyclic amido prostaglandin analogs
JPH02196767A (ja) ヒドロキサム酸誘導体
US5135939A (en) Heterocyclic ketone prostaglandin analogs
CN112812048B (zh) 一种钠离子通道阻滞剂cnv1014802盐酸盐形态的制备方法
US4360685A (en) Dioxatricyclic prostacyclin analogs
JP2561466B2 (ja) フェニルスルホニルアミノアルキルビシクロヘプチルヘプテン酸誘導体
JPS607602B2 (ja) プロスタグランジン誘導体を有効成分として含有する医薬又は獣医薬組成物
EP0497629A1 (en) Heterocyclic amido prostaglandin analogs
JPH0692918A (ja) 2−アミノメチルシクロプロパン−1−カルボン酸類
JPH0378398B2 (zh)
Konno et al. SYNTHESIS AND NEUROEXCITATORY ACTMTY OF SOME ACROMELIC ACID ANALOGS

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed